Article Information
History
- May 14, 2018.
Article Versions
- Version 1 (January 9, 2018 - 07:13).
- Version 2 (January 23, 2018 - 13:10).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Henry Railo*,1,2,3,
- Henri Olkoniemi2,
- Enni Eeronheimo2,
- Oona Pääkkonen2,
- Juho Joutsa4,5,6 and
- Valtteri Kaasinen7,8
- 1Department of Clinical Neurophysiology, University of Turku and Turku University Hospital, FI-20521, Turku, Finland
- 2Department of Psychology, University of Turku, FI-20014, Turku, Finland
- 3Brain and Mind Centre, University of Turku, FI-20014, Turku, Finland
- 4Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129
- 5Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215
- 6Department of Neurology, University of Turku, FI-20521, Turku, Finland
- 7Division of Clinical Neurosciences, University of Turku and Turku University Hospital, FI-20521 Turku, Finland
- 8Turku PET Centre, University of Turku and Turku University Hospital, FI-20521 Turku, Finland
- ↵*Corresponding author: Henry Railo, Department of Psychology, University of Turku, Finland Email: hmrail{at}utu.fi Phone: +358-45-6765227
Posted May 14, 2018.
Dopamine and eye movement control in Parkinson’s disease: deficits in corollary discharge signals?
